According to reports of adverse vaccine events collected by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA), 966 people died after receiving The CDC and the Food and Drug Administration (FDA) collected reports of adverse vaccine events showing that 966 people died after receiving mRNA (messenger ribonucleic acid) vaccine for the CCA virus.
Between Dec. 14 and Feb. 19, the Vaccine Adverse Events Reporting System (VAERS) reported 966 deaths after receiving vaccines from Moderna Pharmaceuticals or mRNA vaccines from U.S. pharmaceutical companies Pfizer and BioNTech (the only two vaccines available during the evaluation period). Events Reporting System (VAERS) received a total of 19,769 reports. Data on VAERS after February 19 are not currently available.
The 966 deaths represent 5% of the total number of reported vaccine adverse events. Of those who died, 86 (8.9%) died on the day of vaccination, another 129 (13.4%) died within one day, 97 died within 2 days, and 61 died within 3 days.
In addition, 514 deaths (53.2%) occurred within one week after injection, 173 deaths within 7-13 days after injection, and 106 deaths within 14-20 days after injection.
According to the report, 85% of the deaths occurred in people over 60 years of age; of the deaths in people under 60 years of age, 5 were between 20-29 years of age; 8 were between 30-39 years of age; 20 were between 40-49 years of age; and 57 were between 50-59 years of age.
Comparison with influenza vaccine
None of the three existing CCP virus mRNA vaccines (Johnson & Johnson (J&J) has also begun offering its own mRNA vaccine since February 19) have yet been approved by the Food and Drug Administration (FDA), but have received Emergency Use Approval (EUA). mRNA vaccines differ from conventional vaccines because they do not use any part of the suspected pathogen to stimulate the immune system, but rather nucleoside-modified RNA. mRNA (modRNA) vaccines get their name from this.
In a petition filed in Europe, Dr. Christian Perrone, director of the Center for Infectious Disease Research at the hôpital de Garches in France, said.
“The first vaccines they provided to us are not vaccines. They are gene therapy products. They are… injected with nucleic acids that cause our own cells to produce the viral component.”
The mortality rate following vaccination with the common virus vaccine (COVID mRNA) is significantly higher than the mortality rate following vaccination with the influenza vaccination (influenza vaccination).
Mortality rates following influenza vaccination can only be approximated based on data from the Centers for Disease Control and Prevention.
The Centers for Disease Control and Prevention reported that 51.8% of Americans were vaccinated during the 2019-2020 influenza season, or about 170 million people.
VAERS, the Vaccine Adverse Event Reporting System, reported that in calendar year 2019 (not the 2019-2020 flu season), there were 45 deaths following influenza vaccination. Comparing background information, in 2018, VAERS reported 46 deaths and in 2017, 20 deaths were reported.
Based on the number of vaccines used in the 2019-2020 influenza season, the 45 cases in 2019 makes the incidence of death after influenza vaccination 0.0000265% .
As of February 19, 41,977,401 doses of Common Central Virus (COVID) vaccine have been administered, of which 966, or approximately 0.0023%, have died after vaccination .
Vaccine Adverse Event Reporting System VAERS
The Vaccine Adverse Event Reporting System (VAERS) was introduced in 1990 to capture unforeseen adverse events during vaccination.
VAERS has been criticized because reports can be submitted by anyone and it only captures a small percentage of adverse events.
The Vaccine Adverse Event Reporting System website describes the system this way.
“Established in 1990, the Vaccine Adverse Event Reporting System (VAERS) is a national early warning system to detect possible safety problems in vaccines licensed for administration in the U.S. VAERS is jointly administered by the Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA). VAERS receives and analyzes VAERS receives and analyzes reports of adverse events (possible side effects) following vaccination. Anyone can report an adverse event to VAERS. Healthcare professionals are required to report certain adverse events, and vaccine manufacturers are required to report all adverse events that come to their attention.
“VAERS is a passive reporting system, meaning that it relies on individuals to submit reports of their experiences to the Centers for Disease Control and the Food and Drug Administration. In this way, VAERS can provide a basis for the reporting of adverse events. In this way, VAERS can provide valuable information to the CDC and FDA, while further evaluation of possible safety hazards requires additional work and assessment.”
In the absence of a medical diagnosis or autopsy, a report of an adverse reaction following vaccination does not prove that the vaccine was necessarily administered to cause a specific symptom.
In a response to the VAERS system’s report of post-injection deaths, Steven (Steven Danehy), Pfizer’s director of global media relations, wrote
“To date, millions of people have been vaccinated with our vaccine. The incidence of serious non-vaccine-related adverse events, including deaths, is likely to be similar to the incidence in the general population.”
Moderna has not responded to requests for comment.
Recent Comments